TD Asset Management
GSK icon

TD Asset Management’s GSK GSK Stock Holding History

TD Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-119,084
Closed -$5.64M – 1366
2020
Q1 		$5.64M Buy
119,084
+32,148
+37% +$1.71M 0.01% 598
2019
Q4 		$5.11M Sell
86,936
-21,279
-20% -$1.18M 0.01% 702
2019
Q3 		$5.77M Sell
108,215
-4,430
-4% -$228K 0.01% 652
2019
Q2 		$5.63M Sell
112,645
-2,367
-2% -$119K 0.01% 653
2019
Q1 		$6.01M Buy
115,012
+66
+0.1% +$3.3K 0.01% 646
2018
Q4 		$5.49M Sell
114,946
-4,555
-4% -$224K 0.01% 632
2018
Q3 		$6M Buy
119,501
+2,251
+2% +$114K 0.01% 670
2018
Q2 		$5.91M Buy
117,250
+1,966
+2% +$99K 0.01% 647
2018
Q1 		$5.63M Buy
115,284
+92,515
+406% +$4.31M 0.01% 646
2017
Q4 		$1.01M Sell
22,769
-6,511
-22% -$301K ﹤0.01% 1049
2017
Q3 		$1.49M Buy
29,280
+1,643
+6% +$83.4K ﹤0.01% 946
2017
Q2 		$1.49M Buy
27,637
+2,159
+8% +$115K ﹤0.01% 945
2017
Q1 		$1.34M Sell
25,478
-1,610
-6% -$81.7K ﹤0.01% 971
2016
Q4 		$1.3M Sell
27,088
-2,246
-8% -$111K ﹤0.01% 959
2016
Q3 		$1.58M Buy
29,334
+557
+2% +$30.5K ﹤0.01% 916
2016
Q2 		$1.46M Sell
28,777
-643
-2% -$33.9K ﹤0.01% 903
2016
Q1 		$1.49M Sell
29,420
-54,805
-65% -$2.73M ﹤0.01% 885
2015
Q4 		$4.25M Sell
84,225
-7,188
-8% -$366K 0.01% 710
2015
Q3 		$4.39M Buy
91,413
+65,563
+254% +$3.41M 0.01% 669
2015
Q2 		$1.53M Buy
25,850
+870
+3% +$49K ﹤0.01% 892
2015
Q1 		$1.48M Sell
24,980
-10,641
-30% -$610K ﹤0.01% 878
2014
Q4 		$1.9M Buy
35,621
+15,606
+78% +$873K ﹤0.01% 849
2014
Q3 		$1.15M Sell
20,015
-12,139
-38% -$744K ﹤0.01% 884
2014
Q2 		$2.15M Buy
32,154
+136
+0.4% +$9.21K ﹤0.01% 821
2014
Q1 		$2.14M Sell
32,018
-434
-1% -$29.3K ﹤0.01% 811
2013
Q4 		$2.17M Sell
32,452
-722
-2% -$46.8K ﹤0.01% 795
2013
Q3 		$2.08M Sell
33,174
-12,784
-28% -$823K ﹤0.01% 793
2013
Q2 		$2.87M Buy
+45,958
New +$2.92M 0.01% 696

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TD Asset Management's GSK Position: Q2 2020 in Review

TD Asset Management sold out of GSK (GSK) in Q2 2020, closing a stake of 119,084 shares — an estimated $5.64M sold.

TD Asset Management first reported a position in GSK in Q2 2013 and held it in 28 quarters. The position peaked at $6.01M in Q1 2019. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • TD Asset Management reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • TD Asset Management sold 119,084 GSK shares in Q2 2020, an estimated $5.64M.
  • TD Asset Management first reported a position in GSK in Q2 2013 and held it in 28 quarters.
  • TD Asset Management's GSK position peaked at $6.01M in Q1 2019.
  • 840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on TD Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.